Alpha Tau Medical (DRTS) Income from Continuing Operations (2021 - 2026)
Alpha Tau Medical (DRTS) posted Income from Continuing Operations of 22950000.0 for Q1 2026, up 88.02% sequentially from 12206000.0 in Q4 2025, and up 170.22% YoY from 8493000.0 in Q1 2025.
Alpha Tau Medical (DRTS) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported Income from Continuing Operations for 6 years, with the latest figure at 22950000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 170.22% year-over-year to 22950000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56842000.0 (up 76.24% YoY) and the FY2025 annual result came in at 42385000.0, up 33.55% from the prior year.
- Income from Continuing Operations advanced to 22950000.0 in Q1 2026 per DRTS's latest filing, from 12206000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 25740000.0 in Q1 2022 and troughed at 1987000.0 in Q2 2022.
- A 5-year average of 9407058.82 and a median of 8145000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations sank 71.42% in 2022, then soared 334.88% in 2023.
- Over 5 years, Income from Continuing Operations stood at 3390000.0 in 2022, then soared by 116.78% to 7349000.0 in 2023, then advanced by 28.89% to 9472000.0 in 2024, then advanced by 28.86% to 12206000.0 in 2025, then soared by 88.02% to 22950000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 22950000.0, 12206000.0, and 11702000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 482.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 237.01 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,096.02 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 164.49 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Alpha Tau Medical | 1.32 Bn | 1.32 Bn | - | -91.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -91.48 Mn |
| Mar 31, 2026 | 22.95 Mn |
| Dec 31, 2025 | 12.21 Mn |
| Sep 30, 2025 | 11.70 Mn |
| Jun 30, 2025 | 9.98 Mn |
| Mar 31, 2025 | 8.49 Mn |
| Dec 31, 2024 | 9.47 Mn |
| Sep 30, 2024 | 6.92 Mn |
| Jun 30, 2024 | 7.36 Mn |
| Mar 31, 2024 | 7.98 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Sep 30, 2023 | 4.99 Mn |
| Jun 30, 2023 | 8.64 Mn |
| Mar 31, 2023 | 8.15 Mn |
| Dec 31, 2022 | 3.39 Mn |
| Sep 30, 2022 | 2.61 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | 25.74 Mn |
| Dec 31, 2021 | 3.81 Mn |
| Sep 30, 2021 | 4.81 Mn |